International Congress on Neuromuscular Diseases 2026 (ICNMD)

Back

HARMONIA: A Global Phase 3 Trial Assessing the Efficacy and Safety of Z-basivarsen in DM1 (poster)

View

Zeleciment Rostudirsen Increased Dystrophin and Led to Functional Improvement in Clinical Measures in DELIVER Trial (poster)

View

Zeleciment Rostudirsen Increased Dystrophin and Led to Functional Improvement in Clinical Measures in DELIVER Trial (supplemental data)

View

FORZETTO, a Phase 3 Study of Z-Rostudirsen in Ambulatory Males with Exon 51 Amenable DMD (poster)

View

©2026 Dyne Therapeutics, Inc. All rights reserved MED-00978. Date of preparation: July 2026.